当前位置:首页 - 行情中心 - 蔚蓝生物(603739) - 财务分析 - 现金流量表

蔚蓝生物

(603739)

  

流通市值:34.34亿  总市值:34.34亿
流通股本:2.53亿   总股本:2.53亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金707,480,406.78376,443,662.81,291,840,327.68978,817,270.22
  收到的税费返还2,336,648.431,665,440.612,496,019.322,628,708.25
  收到其他与经营活动有关的现金24,440,927.896,416,605.2676,331,639.0940,981,913.79
  经营活动现金流入小计734,257,983.1384,525,708.671,370,667,986.091,022,427,892.26
  购买商品、接受劳务支付的现金415,825,838.35206,020,731.88626,485,350.58510,577,249.16
  支付给职工以及为职工支付的现金128,626,327.7577,034,647.91228,550,244.45176,962,134.76
  支付的各项税费50,432,510.7926,296,269.3386,334,252.5269,735,476.78
  支付其他与经营活动有关的现金129,247,674.6867,556,952.79233,890,566.77201,951,216.94
  经营活动现金流出小计724,132,351.57376,908,601.911,175,260,414.32959,226,077.64
  经营活动产生的现金流量净额10,125,631.537,617,106.76195,407,571.7763,201,814.62
二、投资活动产生的现金流量:
  取得投资收益收到的现金558,896.79-16,360,106.4415,236,443.23
  处置固定资产、无形资产和其他长期资产收回的现金净额844.372,7142,077,529.8620,824.24
  处置子公司及其他营业单位收到的现金净额--406,794.34-
  收到的其他与投资活动有关的现金562,880,000242,600,000932,655,482.91631,249,000
  投资活动现金流入小计563,439,741.16242,602,714951,499,913.55646,506,267.47
  购建固定资产、无形资产和其他长期资产支付的现金36,264,988.1841,340,500.86104,719,737.3362,956,067.62
  投资支付的现金437,500-24,375,00016,875,000
  取得子公司及其他营业单位支付的现金--18,360,00018,360,000
  支付其他与投资活动有关的现金520,280,000284,100,495846,503,218.85586,399,000
  投资活动现金流出小计556,982,488.18325,440,995.86993,957,956.18684,590,067.62
  投资活动产生的现金流量净额6,457,252.98-82,838,281.86-42,458,042.63-38,083,800.15
三、筹资活动产生的现金流量:
  吸收投资收到的现金780,000780,000--
  其中:子公司吸收少数股东投资收到的现金780,000780,000--
  取得借款收到的现金365,687,913.25139,470,088.29842,678,389.09573,362,488.53
  筹资活动现金流入小计366,467,913.25140,250,088.29842,678,389.09573,362,488.53
  偿还债务支付的现金383,531,423.2660,050,000915,246,820.27457,350,000
  分配股利、利润或偿付利息支付的现金54,756,913.8413,567,661.7968,902,487.5557,475,911.6
  其中:子公司支付给少数股东的股利、利润21,100,0009,300,00013,668,532.7216,357,000
  支付其他与筹资活动有关的现金---43,698,482.2
  筹资活动现金流出小计438,288,337.173,617,661.79984,149,307.82558,524,393.8
  筹资活动产生的现金流量净额-71,820,423.8566,632,426.5-141,470,918.7314,838,094.73
四、汇率变动对现金及现金等价物的影响--126,900.55-
五、现金及现金等价物净增加额-55,237,539.34-8,588,748.611,605,510.9639,956,109.2
  加:期初现金及现金等价物余额233,326,458.32233,326,458.32221,720,947.36221,720,947.36
  期末现金及现金等价物余额178,088,918.98224,737,709.72233,326,458.32261,677,056.56
补充资料:
  净利润39,804,417.47-92,172,274.48-
  资产减值准备-860,799.97-2,684,134.98-
  固定资产和投资性房地产折旧50,304,782.76-101,247,766.7-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧50,304,782.76-101,247,766.7-
  无形资产摊销4,525,179.76-9,738,713.12-
  长期待摊费用摊销558,371.59-1,207,508.1-
  处置固定资产、无形资产和其他长期资产的损失-393,279.13-602,390.96-
  固定资产报废损失--475,657.22-
  公允价值变动损失-4,166,982.33--8,317,637.54-
  财务费用8,582,869.11-21,878,828.93-
  投资损失126,522.53-1,239,485.35-
  递延所得税-3,595,388.71--493,706.13-
  其中:递延所得税资产减少-4,538,589.18-1,071,641.33-
    递延所得税负债增加943,200.47--1,565,347.46-
  存货的减少-34,651,439.93-13,844,769.31-
  经营性应收项目的减少-24,674,637.59--40,879,324.66-
  经营性应付项目的增加-28,394,707.89--6,460,650.3-
  现金的期末余额178,088,918.98-233,326,458.32-
  减:现金的期初余额233,326,458.32-221,720,947.36-
  现金及现金等价物的净增加额-55,237,539.34-11,605,510.96-
公告日期2025-08-282025-04-262025-04-262024-10-29
审计意见(境内)标准无保留意见
TOP↑